Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Investigators based at the Kennedy Institute of Rheumatology, NDORMS have recently received CRUK awards to increase understanding of a variety of cancers and immunotherapy.

AUDREY GÉRARD

Audrey Gérard, has been awarded a CRUK Immunology Project Award to look at the mechanisms inhibiting anti-tumour immunity. There has been unprecedented success in treating aggressive cancers with checkpoint blockade, immunotherapy that stimulates the body's own immune system to eliminate cancer cells. But more research is needed to determine whether there are other checkpoints restricting tumour immunity that could be therapeutically exploited to improve treatment where there has been less success.

"This award is a fantastic opportunity for us to expand our fundamental work on the feedback mechanisms regulating the immune system. It will allow us to investigate how this regulation is co-opted by cancer cells to evade the immune system."

ANJALI KUSUMBE, RICHARD WILLIAMS AND FELIX CLANCHY

Anjali Kusumbe, Richard Williams and Felix Clanchy were granted a CRUK Early Detection Primer Award to research Ewing's Sarcoma, a highly malignant tumour that occurs in the bone or surrounding tissue, usually treated with chemotherapy and surgery or radiotherapy. But the spread of the disease and recurrence after therapy is associated with poor prognosis. To detect recurrence, patients undertake periodic chest X-rays, blood tests and remain vigilant for symptoms such as bone pain. The research proposes to improve the current method for the detection of relapse or occult disease at the end of treatment.

"This project brings together Anjali, Richard and Felix as researchers with an interest in bone cancer, pain, and detection of rare cells respectively. The funding will allow the team to consolidate and extend previous work in the development of models and tools to stratify patients according to risk of disease."

ALEX CLARKE

With his Cancer Immunology grant, Alex Clarke will explore how one-carbon (1C) metabolism in germinal centre B cells promotes autoimmunity and lymphoma. The aim of this project is to study and interfere with a vital pathway in which cells synthesise the amino acid serine from glucose, an important building block for cell growth.

"This award provides an exciting opportunity to apply the expertise my lab has developed in immune metabolism to understanding the origins of lymphoma, which we often see complicating autoimmune disease. We hope that identifying metabolic pathways shared between autoimmune B cells and lymphoma will pave the way for new treatment approaches which can be used across both diseases."

Similar stories

EPSRC funds research to avert an antibiotics apocalypse

Researchers at the Kennedy Institute join a collaboration to find new ‘drug-free’ ways of treating illnesses where current treatments have become ineffective due to antibiotic resistance.

Major ERC funding awarded to Professor Michael Dustin

Professor Michael Dustin and an international team of collaborators have been awarded a €10M grant from the European Research Council (ERC) to develop a new biotechnology around supramolecular attack particles (SMAPs) engineered to kill cancer cells.

Oxford University awarded £2.4 million to fund DPhil research in inflammation, immunology and musculoskeletal disease

Oxford University has today been awarded a £2.4 million grant, as part of the Kennedy Trust MB PhD scheme, to fund undergraduate medical students to undertake DPhil research in the areas of inflammation, immunology and musculoskeletal disease.

Kennedy Trust renews commitment to rheumatology research with £20M

The Kennedy Trust for Rheumatology Research (KTRR) has pledged a minimum of £20M over five years to the Kennedy Institute of Rheumatology at the University of Oxford to support pioneering research into chronic inflammatory disease.

Kennedy researchers awarded MRC funding for arthritis research

Congratulations to Kennedy researchers Professor Chris Buckley, Professor Mark Coles and Dr Stephen Sansom who have been awarded £1.5M funding from the Medical Research Council (MRC) to explore fibroblasts as an emerging target to treat chronic inflammatory disease.